11 March 2013
Drug Research Shows Potential to Delay Onset or Progression of Alzheimer’s Disease
Drapladib reduces leaks in blood-brain barrier that could cause disease. A research team led by Robert Nagele, PhD, of the New Jersey Institute for Successful Aging (NJISA) at the University of Medicine and Dentistry of New Jersey (UMDNJ)-School of Osteopathic Medicine, has demonstrated
5 February 2013
Vitamin D, omega-3 may help clear amyloid plaques found in Alzheimer's
Los Angeles, CA, USA - A team of academic researchers has pinpointed how vitamin D3 and omega-3 fatty acids may enhance the immune system's ability to clear the brain of amyloid plaques, one of the hallmarks of Alzheimer's disease.
24 January 2013
Exercise can slow onset of Alzheimer’s memory loss — scientists identify link
Keeping active can slow down the progression of memory loss in people with Alzheimer’s disease, a study has shown.
12 December 2012
Method developed by VTT targets diagnosis of early Alzheimer’s disease
A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer’s disease currently takes on average 20 months to diagnose in Europe.
5 November 2012
Controlling Vascular Disease May Be Key to Reducing Prevalence of Alzheimer’s Disease
Amsterdam, NL – Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer’s disease. In a special issue of the Journal of Alzh
16 October 2012
Eating Lots of Carbs, Sugar May Raise Risk of Cognitive Impairment, Mayo Clinic Study Finds
Rochester, Minn, USA, — People 70 and older who eat food high in carbohydrates have nearly four times the risk of developing mild cognitive impairment, and the danger also rises with a diet heavy in sugar, Mayo Clinic researchers have found.
29 August 2012
New Diagnostic Biomarkers Offer Ray of Hope for Alzheimer's Disease
State-of-the-Art Imaging Technology for Biomarker Development Explored in a Supplement to Journal of Alzheimer’s Disease. Alzheimer’s disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide.
Pages
